Immune-Boosting Gel Could Stem Spread Of Cancer After Surgery, Mouse Study Suggests

Researchers at the Dana-Farber Cancer Institute have found that in mice, implanting a small disc of gel during surgery that slowly releases an immune-boosting drug afterward appears to help keep the cancer from recurring. The researchers tested more than a hundred mice with breast cancer, lung cancer or melanoma. After their tumors were removed, the … Read more

Gradual release of immunotherapy at site of tumor surgery prevents tumors from returning and eliminates cancer spread in mouse study

A new study by Dana-Farber Cancer Institute scientists suggests it may be possible to prevent tumors from recurring and to eradicate metastatic growths by implanting a gel containing immunotherapy during surgical removal of a tumor. In the study, published online today by Science Translational Medicine, researchers removed breast tumors from mice and placed biodegradable gels containing … Read more

Bristol-Myers Squibb Awards “Golden Tickets” for LabCentral to Carmine Therapeutics, STIMIT

PRINCETON, N.J. & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE:BMY) and LabCentral, an innovative, shared laboratory space designed as a launchpad for life sciences and biotech startups, today announced that Carmine Therapeutics and STIMIT are the winners of Bristol-Myers Squibb’s 2019 Golden Tickets for LabCentral. As a platinum sponsor of LabCentral, Bristol-Myers Squibb can select up to two … Read more